These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11219276)

  • 1. [Homocysteine--CRP--lipoprotein (a). When do you evaluate the "new" risk factors].
    Parhofer KG
    MMW Fortschr Med; 2001 Jan; 143(4):22-4. PubMed ID: 11219276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Less common risk factors for atherogenesis--homocysteine, lipoprotein (a) and C-reactive protein].
    Racek J; Racková M
    Cas Lek Cesk; 2002 Sep; 141(19):605-9. PubMed ID: 12501503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Novel risk factors for atherosclerosis. A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a) and cholesterol as predictors of peripheral arteriopathy].
    Iacoviello L; Donati MB; de Gaetano G
    Ital Heart J Suppl; 2001 Sep; 2(9):1031-3. PubMed ID: 11675827
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of rosiglitazone on novel atherosclerotic risk factors in patients with type 2 diabetes mellitus and hypertension. An open-label observational study.
    Sarafidis PA; Lasaridis AN; Nilsson PM; Mouslech TF; Hitoglou-Makedou AD; Stafylas PC; Kazakos KA; Yovos JG; Tourkantonis AA
    Metabolism; 2005 Sep; 54(9):1236-42. PubMed ID: 16125536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein but not soluble CD40 ligand and homocysteine is associated to common atherosclerotic risk factors in a cohort of coronary artery disease patients.
    Vivona N; Bivona G; Noto D; Sasso BL; Cefalù AB; Chiarello G; Falletta A; Ciaccio M; Averna MR
    Clin Biochem; 2009 Nov; 42(16-17):1713-8. PubMed ID: 19732763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [C-reactive protein and homocysteine as risk factors of atherosclerosis].
    Jarosz A; Nowicka G
    Przegl Lek; 2008; 65(6):268-72. PubMed ID: 18853656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atherosclerotic renal artery stenosis: association with emerging vascular risk factors.
    Paraskevas KI; Hamilton G; Cross JM; Mikhailidis DP
    Nephron Clin Pract; 2008; 108(1):c56-66. PubMed ID: 18097149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The emerging risk factors for cardiovascular disease: a review of the epidemiologic evidence for lipoprotein(a), homocysteine, and fibrinogen.
    Catena C; Cavarape A; Dotto L; Colussi G; Novehllo M; De Marchi S; Sechi LA
    Adv Clin Path; 2003 Jan; 7(1):3-11. PubMed ID: 19774732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased lipoprotein(a) in metabolic syndrome: is it a contributing factor to premature atherosclerosis?
    Bozbaş H; Yildirir A; Pirat B; Eroğlu S; Korkmaz ME; Atar I; Ulus T; Aydinalp A; Ozin B; Müderrisoğlu H
    Anadolu Kardiyol Derg; 2008 Apr; 8(2):111-5. PubMed ID: 18400630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homocysteine and C-reactive protein are not markers of cognitive impairment in patients with major cardiovascular disease.
    Silbert B; Evered L; Scott DA; McCutcheon C; Jamrozik K
    Dement Geriatr Cogn Disord; 2008; 25(4):309-16. PubMed ID: 18311078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease.
    Bleie Ø; Semb AG; Grundt H; Nordrehaug JE; Vollset SE; Ueland PM; Nilsen DW; Bakken AM; Refsum H; Nygård OK
    J Intern Med; 2007 Aug; 262(2):244-53. PubMed ID: 17645592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of homocysteine, C-reactive protein and bilirubin for coronary artery disease.
    Yilmaz N; Ciçek HK; Celik A; Meram I; Kocabas R; Davutoglu V
    East Mediterr Health J; 2007; 13(3):522-35. PubMed ID: 17687824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma pyridoxal 5'-phosphate and high-sensitivity C-reactive protein are independently associated with an increased risk of coronary artery disease.
    Cheng CH; Lin PT; Liaw YP; Ho CC; Tsai TP; Chou MC; Huang YC
    Nutrition; 2008 Mar; 24(3):239-44. PubMed ID: 18312786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conditional risk factors for atherosclerosis.
    Kullo IJ; Ballantyne CM
    Mayo Clin Proc; 2005 Feb; 80(2):219-30. PubMed ID: 15704777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence.
    Hackam DG; Anand SS
    JAMA; 2003 Aug; 290(7):932-40. PubMed ID: 12928471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homocysteinemia as an independent risk factor in the Chinese population at a high risk of coronary artery disease.
    Ni M; Zhang XH; Jiang SL; Zhang Y
    Am J Cardiol; 2007 Aug; 100(3):455-8. PubMed ID: 17659928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel risk factors for atherosclerosis.
    Kullo IJ; Gau GT; Tajik AJ
    Mayo Clin Proc; 2000 Apr; 75(4):369-80. PubMed ID: 10761492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma concentrations of C-reactive protein and total homocysteine in relation to the severity and risk factors for cerebrovascular disease.
    Youssef MY; Mojiminiyi OA; Abdella NA
    Transl Res; 2007 Sep; 150(3):158-63. PubMed ID: 17761368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis.
    Wållberg-Jonsson S; Cvetkovic JT; Sundqvist KG; Lefvert AK; Rantapää-Dahlqvist S
    J Rheumatol; 2002 May; 29(5):875-82. PubMed ID: 12022343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemostasis and atherosclerosis.
    Warkentin TE
    Can J Cardiol; 1995 May; 11 Suppl C():29C-34C. PubMed ID: 7750046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.